Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade

Journal of Virology

Volumn 74, Issue 1, 2000, Pages 428-435

  Hanabuchi, Shino ^a   Ohashi, Takashi ^a   Koya, Yoshihiro ^a   Kato, Hirotomo ^a,c   Takemura, Fumiyo ^a,e   Hirokawa, Katsuiku ^b   Yoshiki, Takashi ^f   Yagita, Hideo ^d,e   Okumura, Ko ^d,e   Kannagi, Mari ^a,c,e  

^a Depts of Immunotherapeutics   (Japan)

^b Depts of Pathology and Immunology   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BLOCKING ANTIBODY; CD86 ANTIGEN; MONOCLONAL ANTIBODY;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; IMMUNOSURVEILLANCE; LUNG METASTASIS; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR; T LYMPHOCYTE; VIRUS CARCINOGENESIS;

EID: 0033986884     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.1.428-435.2000     Document Type: Article

References (47)

1. Akagi, T., H. Ono, and K. Shimotohno. 1995. Characterization of T cells immortalized by Tax 1 of human T-cell leukemia virus type 1. Blood 86: 4243-4249.
2. Azuma, M., D. Itoh, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76-79.
3. Baum, P. R., R. B. Gayle III, F. Ramsdell, S. Srinivasan, R. A. Sorensen, M. L. Watson, M. F. Seldin, E. Baker, G. R. Sutherland, and K. N. Clifford. 1994. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13:3992-4001.
4. Boussiotis, V., G. Freeman, G. Gray, J. Gribben, and L. Nadler. 1993. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J. Exp. Med. 178:1753-1763.
5. Brunner, K. T., J. Mauel, J. C. Cerottini, and B. Chapuis. 1968. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogenic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181-196.
6. Dao, T., V. Holan, and J. Minowada. 1993. Multiple and heterogeneous patterns of cytokine production in 18 leukemia and in vitro transformed mature T cell lines reflect the individuality of human leukemias. Int. J. Hematol. 57:139-146.
7. Dezzuti, C. S., D. L. Rudolph, and R. B. Lal. 1995. Infection with human T-lymphotropic virus type I and II results in alterations of cellular receptors, including the up-modulation of T cell counterreceptors CD40, CD54 and CD80 (B7-1). Clin. Diagn. Lab. Immunol. 2:349-355.
8. Freedman, A. S., and G. Freeman. 1987. B7, a B-cell-restricted antigen that identifies preactivated B cells. J. Immunol. 139:3260-3267.
9. Freeman, G., J. Gribben, V. Boussiotis, V. Restivo, J. L. Lombard, G. Gray, and L. Nadler. 1993. Cloning of B7-2: a counter-receptor that costimulates human T cell proliferation. Science 262:909-911.
10. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
11. Gessain, A., A. Louie, O. Gout, R. C. Gallo, and G. Franchini. 1991. Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/ HTLV-I-associated myelopathy. J. Virol. 65:1628-1633.
12. Gimmi, C., G. Freeman, J. Gribben, K. Sugita, A. Freeman, C. Morimoto, and L. Nadler. 1991. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88:6575-6579.
13. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. I. Kinoshita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476-6480.
14. Ishiguro, N., M. Abe, K. Seto, H. Sakurai, H. Ikeda, A. Wakisaka, T. Togashi, M. Tateno, and T. Yoshiki. 1992. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J. Exp. Med. 176:981-989.
15. Itoyama, Y., S. Minato, I. Goto, K. Okochi, and N. Yamamoto. 1988. Elevated serum antibody titers to Epstein-Barr virus in HTLV-I-associated myelopathy (HAM). Neurology 38:1650-1653.
16. Jacobson, S., H. Shida, D. E. McFarlin, A. S. Fauci, and S. Koenig. 1990. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245-248.
17. Jenkins, M. K., P. S. Taylor, S. D. Norton, and K. B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461-2466.
18. Kannagi, M., S. Harada, I. Maruyama, H. Inoko, H. Igarashi, G. Kuwashima, S. Sato, M. Morita, M. Kidokoro, M. Sugimoto, S.-I. Funahashi, M. Osame, and H. Shida. 1991. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 3:761-767.
19. Kannagi, M., S. Matsushita, and S. Harada. 1993. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells. Int. J. Cancer 54:582-588.
20. Kannagi, M., K. Sugamura, K.-I. Kinoshita, H. Uchino, and Y. Hinuma. 1984. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. J. Immunol. 133: 1037-1041.
21. Koulova, L., E. A. Clark, G. Shu, and B. Dupont. 1991. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J. Exp. Med. 173:759-762.
22. Lal, R. B., D. L. Rudolph, C. S. Dezzutti, P. S. Linsley, and H. E. Prince. 1996. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types 1 and H are mediated through CD80 and CD86 ligands. I. Immunol. 157:1288-1296.
23. Lenschow, D. J., Y. Zeng, R. Thistlewaite, A. Montag, W. Bailey, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogenic pancreatic islet grafts induced CTLA-4-Ig. Science 257:789-792.
24. Linsley, P. S., W. Bradj, L. Brosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. CTLA4 is a second receptor for the B-cell activation antigen B7. J. Exp. Med. 174:561-569.
25. Linsley, P. S., W. Brady, L. Grosmaire, and A Aruffo. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721-730.
26. Linsley, P. S., E. A. Clark, and J. A Ledbetter. 1990. The T cell antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen, B7/BB-1. Proc. Natl. Acad. Sci. USA 87:5031-5035.
27. Maeda, K., T. Sato, M. Azuma, H. Yagita, and K. Okumura. 1997. Characterization of rat CD80 and CD86 by molecular cloning and mAb. Int. Immunol. 9:993-1000.
28. Mitsuya, H., L. A. Matis, M. Megson, P. A. Bunn, C. Murray, D. L. Mann, R C. Gallo, and S. Broder. 1983. Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus. J. Exp. Med. 158:994-999.
29. Ohashi, T., S. Hanabuchi, H. Kato, Y. Koya, F. Takemura, K. Hirokawa, T. Yoshiki, Y. Tanaka, M. Fujii, and M. Kannagi. 1999. Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells. J. Virol. 73:6031-6040.
30. Oka, T., H. Sonobe, J. Iwata, I. Kubonishi, H. Satoh, M. Takata, Y. Tanaka, M. Tateno, H. Tozawa, S. Mori, T. Yoshiki, and Y. Ohtsuki. 1992. Phenotypic progression of a rat lymphoid cell line immortalized by human T-lymphotropic virus type I to induce lymphoma/leukemia-like disease in rats. J. Virol. 66:6686-6694.
31. Parker, C. E., S. Daenke, S. Nightingale, and C. R. Bangham. 1992. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in health sero-positives as well as in patients with tropical spastic paraparesis. Virology 188:628-636.
32. Poiesz, B. J., F. W. Huscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
33. Schwartz, R. T. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349-1356.
34. Simpson, R. M., T. M. Zhao, B. S. Hubbard, S. Sawasdikosol, and T. J. Kindt. 1996. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection. Lab. Investig. 74:696-710.
35. Sugamura, K., M. Fujii, M. Kannagi, M. Sakitani, M. Takeuchi, and Y. Hinuma. 1984. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int. J. Cancer 34:221-228.
36. Tan, P., C. Anasetti, and J. A. Hansen. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165-173.
37. Tanaka, A., C. Takahashi, S. Yamaoka, T. Nosaka, M. Maki, and M. Hatanaka. 1990. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc. Natl. Acad. Sci. USA 87:1071-1075.
38. Tanaka, Y., K. Fukudome, M. Hayashi, S. Takagi, and O. Yoshie. 1995. Induction of ICAM-1 and LFA-3 by taxi of human T-cell leukemia virus type I and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell leukemia cell lines. Int. J. Cancer 60:554-561.
39. Tanaka, Y., H. Tozawa, Y. Koyanagi, and H. Shida. 1990. Recognition of human T cell leukemia virus type I (HTLV-1) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells. J. Immunol. 144:4202-4211.
40. Tateno, M., N. Kondo, T. Itoh, T. Chubachi, T. Togashi, and T. Yoshiki. 1984. Rat lymphoid cell lines with human T cell leukemia virus production. J. Exp. Med. 159:1105-1116.
41. Tendler, C. L., S. J. Greenberg, W. A. Blattner, A. Manns, E. Murphy, T. Fleisher, B. Hanchard, O. Morgan, J. D. Burton, and D. L. Nelson. 1990. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc. Natl Acad. Sci. USA 87:5218-5222.
42. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R.-Q. Wei, M. L. Gibson, X.-G. Zheng, S. Myrdal, D. Gordon, T. Bailey, S. F. Bolling, and C. B. Thompson. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Prof. Natl. Acad. Sci. USA 89:11102-11105.
43. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481-442.
44. Usuku, K., S. Sonoda, M. Osame, S. Yashiki, K. Takahashi, M. Matsumoto, T. Sawada, K. Tsuji, M. Tara, and A. Igata. 1488. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann. Neurol. 23: S143-S150.
45. Yokochi, T., and R. D. Holly. 1982. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus activated B cell blasts. B lymphoblastoid cell lines, and Burkitt's lymphomas. J. Immunol. 128:823-827.
46. Yoshida, M., M. Osame, H. Kawai, M. Toita, N. Kuwasaki, Y. Nishida, Y. Hiraki, K. Takahashi, K. Nomura, S. Sonoda, N. Eiraku, S. Ijichi, and K. Usuku. 1989. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann. Neurol. 26:331-335.
47. Yoshida, M., M. Osame, K. Usuku, K. Matsumoto, and A. Igata. 1987. Viruses detected in HTLV-I associated myelopathy and adult T-cell leukemia are identical on DNA blotting. Lancet i:1085-1086.